You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

rozanolixizumab

Showing 1 - 15 of 15
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Generalized Myasthenia Gravis Trial (rozanolixizumab)

Not yet recruiting
  • Generalized Myasthenia Gravis
  • rozanolixizumab
  • (no location specified)
Nov 28, 2023

Generalized Myasthenia Gravis Trial (Rozanolixizumab)

Not yet recruiting
  • Generalized Myasthenia Gravis
  • Rozanolixizumab
  • (no location specified)
Jan 4, 2023

Fibromyalgia Trial in Liverpool (rozanolixizumab, Placebo)

Recruiting
  • Fibromyalgia
  • rozanolixizumab
  • Placebo
  • Liverpool, United Kingdom
    Fm0001 4404
Jan 13, 2023

Healthy Study Participants Trial in London (rozanolixizumab, Placebo)

Completed
  • Healthy Study Participants
  • rozanolixizumab
  • Placebo
  • London, United Kingdom
    Up0106 001
Jan 9, 2023

Leucine-Rich Glioma Inactivated 1 Autoimmune Encephalitis Trial in Worldwide (Rozanolixizumab, Placebo)

Recruiting
  • Leucine-Rich Glioma Inactivated 1 Autoimmune Encephalitis
  • Rozanolixizumab
  • Placebo
  • Aurora, Colorado
  • +21 more
Feb 2, 2023

Primary Immune Thrombocytopenia Trial in Worldwide (Rozanolixizumab)

Completed
  • Primary Immune Thrombocytopenia
  • Rozanolixizumab
  • Boston, Massachusetts
  • +26 more
Jan 16, 2023

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Trial (Rozanolixizumab)

Available
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
  • Rozanolixizumab
  • (no location specified)
Aug 19, 2021

Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Trial in Worldwide (Rozanolixizumab)

Completed
  • Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
  • Rozanolixizumab
  • Scottsdale, Arizona
  • +13 more
Mar 31, 2022

Healthy-volunteers Trial in London (Rozanolixizumab, Placebo)

Completed
  • Healthy-volunteers
  • Rozanolixizumab
  • Placebo
  • London, United Kingdom
    UP0060 1
Sep 15, 2021

Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOG-AD) Trial in Worldwide (Rozanolixizumab, Placebo)

Recruiting
  • Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOG-AD)
  • Rozanolixizumab
  • Placebo
  • Scottsdale, Arizona
  • +43 more
Feb 2, 2023

Primary Immune Thrombocytopenia Trial in Worldwide (Rozanolixizumab, Placebo)

Terminated
  • Primary Immune Thrombocytopenia
  • Rozanolixizumab
  • Placebo
  • Beverly Hills, California
  • +48 more
Aug 17, 2022

Generalized Myasthenia Gravis Trial in Worldwide (Rozanolixizumab)

Active, not recruiting
  • Generalized Myasthenia Gravis
  • Rozanolixizumab
  • Orange, California
  • +68 more
Jul 18, 2022

Generalized Myasthenia Gravis Trial in Worldwide (Rozanolixizumab)

Completed
  • Generalized Myasthenia Gravis
  • Rozanolixizumab
  • Phoenix, Arizona
  • +36 more
Sep 27, 2021

Primary Immune Thrombocytopenia Trial in Worldwide (Rozanolixizumab, Placebo)

Recruiting
  • Primary Immune Thrombocytopenia
  • Rozanolixizumab
  • Placebo
  • Louisville, Kentucky
  • +75 more
Apr 7, 2022

Generalized Myasthenia Gravis Trial in Worldwide (Rozanolixizumab, Placebo)

Completed
  • Generalized Myasthenia Gravis
  • Rozanolixizumab
  • Placebo
  • Phoenix, Arizona
  • +91 more
Nov 25, 2021